Letter
Nature 445, 214-218 (11 January 2007) | doi:10.1038/nature05458; Received 9 August 2006; Accepted 17 November 2006
Histone arginine methylation regulates pluripotency in the early mouse embryo
Maria-Elena Torres-Padilla1, David-Emlyn Parfitt1, Tony Kouzarides1 & Magdalena Zernicka-Goetz1
- The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK
Correspondence to: Magdalena Zernicka-Goetz1 Correspondence and requests for materials should be addressed to M.Z.-G. (Email: mzg@mole.bio.cam.ac.uk).
It has been generally accepted that the mammalian embryo starts its development with all cells identical, and only when inside and outside cells form do differences between cells first emerge. However, recent findings show that cells in the mouse embryo can differ in their developmental fate and potency as early as the four-cell stage1, 2, 3, 4. These differences depend on the orientation and order of the cleavage divisions that generated them2, 5. Because epigenetic marks are suggested to be involved in sustaining pluripotency6, 7, we considered that such developmental properties might be achieved through epigenetic mechanisms. Here we show that modification of histone H3, through the methylation of specific arginine residues, is correlated with cell fate and potency. Levels of H3 methylation at specific arginine residues are maximal in four-cell blastomeres that will contribute to the inner cell mass (ICM) and polar trophectoderm and undertake full development when combined together in chimaeras. Arginine methylation of H3 is minimal in cells whose progeny contributes more to the mural trophectoderm and that show compromised development when combined in chimaeras. This suggests that higher levels of H3 arginine methylation predispose blastomeres to contribute to the pluripotent cells of the ICM. We confirm this prediction by overexpressing the H3-specific arginine methyltransferase CARM1 in individual blastomeres and show that this directs their progeny to the ICM and results in a dramatic upregulation of Nanog and Sox2. Thus, our results identify specific histone modifications as the earliest known epigenetic marker contributing to development of ICM and show that manipulation of epigenetic information influences cell fate determination.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Developmental biology Marked from the startNature News and Views (11 Jan 2007)
Cloning by numbersNature Biotechnology News and Views (01 Dec 2003)
RESEARCH
Is the nitric oxide system involved in genetic hypertension in Dahl rats?Kidney International Original Article
Function of human renin proximal promoter DNAKidney International Original Article
See all 42 matches for Research